Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
Public ClinicalTrials.gov record NCT04645212. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-term Study of ADVM-022 in Neovascular (Wet) AMD - OPTIC Extension
Study identification
- NCT ID
- NCT04645212
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Adverum Biotechnologies, Inc.
- Industry
- Enrollment
- 23 participants
Conditions and interventions
Interventions
- ADVM-022 Biological
Biological
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 13, 2020
- Primary completion
- Jun 25, 2030
- Completion
- Jun 25, 2030
- Last update posted
- Feb 9, 2026
2020 – 2030
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Adverum Clinical Site | Bakersfield | California | 93309 | — |
| Adverum Clinical Site | Beverly Hills | California | 90211 | — |
| Adverum Clinical Site | Lakewood | Colorado | 80228 | — |
| Adverum Clinical Site | Deerfield Beach | Florida | 33064 | — |
| Adverum Clinical Site | Reno | Nevada | 89502 | — |
| Adverum Clinical Site | Philadelphia | Pennsylvania | 19107 | — |
| Adverum Clinical Site | Nashville | Tennessee | 37203 | — |
| Adverum Clinical Site | Bellaire | Texas | 77401 | — |
| Adverum Clinical Site | The Woodlands | Texas | 77384 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04645212, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04645212 live on ClinicalTrials.gov.